Avicanna Inc. Share Price
Stocks
AVCN
CA05368K1003
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Toronto S.E.
19:26:51 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1050 CAD | 0.00% |
|
0.00% | -53.33% |
| 08-19 | Avicanna Inc. announced that it has received CAD 0.5 million in funding | CI |
| 08-19 | Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter | MT |
| Market Cap | 14.46M 10.23M 8.97M 8.48M 7.72M 980M 14.56M 101M 39.29M 501M 38.4M 37.57M 1.61B | P/E 2024 |
-8.43x | P/E 2025 | -9.36x |
|---|---|---|---|---|---|
| Enterprise Value | 14.18M 10.03M 8.8M 8.31M 7.57M 961M 14.28M 99.47M 38.52M 491M 37.66M 36.84M 1.58B | EV / Sales 2024 |
1.31x | EV / Sales 2025 | 1.03x |
| Free-Float |
78.71% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| AVCN | Delayed | |
OTC Markets
| AVCNF | Delayed | |
|
Deutsche Boerse AG
| 0NN | Delayed | |
|
Boerse Muenchen
| 0NN | Real-time | |
|
Börse Stuttgart
| 0NN | Delayed |
Last Transcript: Avicanna Inc.
| Current month | -19.23% | ||
| 1 month | -19.23% | ||
| 3 months | -16.00% | ||
| 6 months | -32.26% | ||
| Current year | -53.33% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.13 |
| Current year | 0.1 | | 0.24 |
| 1 year | 0.1 | | 0.3 |
| 3 years | 0.1 | | 0.6 |
| 5 years | 0.1 | | 0.97 |
| 10 years | 0.1 | | 7.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ivana Maric
SAM | Sales & Marketing | - | 30/04/2015 |
Aras Azadian
CEO | Chief Executive Officer | 39 | 25/11/2016 |
Nick Hilborn
DFI | Director of Finance/CFO | - | 14/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Aras Azadian
CHM | Chairman | 39 | 25/11/2016 |
| Director/Board Member | - | 21/10/2018 | |
Michael Kott
BRD | Director/Board Member | - | 31/12/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/09/26 | Buy | Director | 233,000 | 0.1734% | ||
| 12/06/26 | Sell | Director | 333,000 | 0.2647% | ||
| 27/05/26 | Buy | Director | 160,000 | 0.1272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -58.00% | -76.92% | 10.23M | |
| -0.14% | +4.33% | +9.88% | +31.73% | 47.97B | |
| -1.69% | +1.48% | +53.02% | +33.59% | 44.5B | |
| +2.56% | +7.34% | +382.17% | +594.81% | 43.93B | |
| +0.24% | +2.85% | +9.78% | +89.54% | 41.03B | |
| -0.62% | -1.11% | +4.70% | +46.02% | 29.85B | |
| -0.28% | +1.07% | +26.83% | +152.91% | 17.27B | |
| -0.46% | +1.20% | +26.78% | +41.32% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| +3.37% | +9.21% | +9.93% | - | 15.34B | |
| Average | +0.08% | +2.12% | +51.68% | +114.13% | 27B | |
| Weighted average by Cap. | +0.11% | +2.86% | +83.03% | +156.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 25.46M 18.01M 15.8M 14.92M 13.6M 1.73B 25.64M 179M 69.17M 882M 67.61M 66.15M 2.83B | 25.48M 18.02M 15.81M 14.94M 13.61M 1.73B 25.66M 179M 69.22M 882M 67.66M 66.2M 2.84B |
| Net income | -3.62M -2.56M -2.25M -2.12M -1.93M -245M -3.64M -25.38M -9.83M -125M -9.61M -9.4M -403M | -2.76M -1.95M -1.71M -1.62M -1.47M -187M -2.78M -19.35M -7.5M -95.56M -7.33M -7.17M -307M |
| Net Debt | -339K -240K -210K -199K -181K -22.97M -341K -2.38M -920K -11.73M -900K -880K -37.71M | -281K -198K -174K -165K -150K -19.02M -283K -1.97M -762K -9.72M -745K -729K -31.24M |
Employees
112
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | CA$0.1050 | 0.00% | 47,500 |
| 24/09/26 | CA$0.1050 | 0.00% | 9,500 |
| 22/09/26 | CA$0.1050 | 0.00% | 52,770 |
| 21/09/26 | CA$0.1050 | 0.00% | 16,300 |
| 18/09/26 | CA$0.1050 | -4.55% | 91,000 |
- Stock Market
- Stocks
- AVCN Stock
Select your edition
All financial news and data tailored to specific country editions
